Arteriosclerosis and Thrombosis, Vol 14, 707-720, Copyright © 1994 by American Heart Association

ARTICLES

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution

EA Brinton, S Eisenberg and JL Breslow
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, NY.

High-density lipoprotein (HDL) cholesterol (HDL-C) levels are a strong inverse predictor of atherosclerosis risk, but the physiological determinants of HDL-C levels are poorly understood. We selected 57 human subjects (30 women and 27 men) with a broad range of HDL-C levels and performed turnover studies of apolipoprotein (apo)A-I and apoA-II, the two major apolipoproteins of HDL, to measure the fractional catabolic rate (FCR) and production or transport rate (TR) of these proteins. We also measured several other parameters known to correlate with HDL-C levels to test for their interrelations and to postulate mechanisms of regulation of HDL-C levels. As expected, the women had higher levels of HDL-C (56.7 +/- 21.4 versus 45.1 +/- 16.3 mg/dL, mean +/- SD; P = .03) and apoA-I (147 +/- 32 versus 126 +/- 29 mg/dL, P = .01) than men and did not differ in apoA-II levels (34.5 +/- 7.4 versus 33.3 +/- 7.5 mg/dL, P > .2). The FCR of apoA-I tended to be lower in the women (0.248 +/- 0.077 versus 0.277 +/- 0.069 pools/d, P = .1), although the difference was not statistically significant. The FCR of apoA-II was also lower (0.184 +/- 0.043 versus 0.216 +/- 0.056 pools/d, P = .02). In contrast, the apoA-I TR was equal in women and men (12.0 +/- 1.6 versus 12.1 +/- 2.8 mg/kg per day, P > .2), and there was a trend toward lower apoA-II TR in women (2.19 +/- .62 versus 2.61 +/- 1.06 mg/kg per day, P = .07). Linear regression analysis revealed a strong inverse correlation between HDL-C levels and the FCRs of apoA-I and apoA-II (r = -.81 and -.76, respectively; P < .0001 for both). In contrast, there was little or no association between HDL-C and the TRs of apoA-I and apoA-II (r = .06 and -.35, P = not significant and .01, respectively). In stepwise multiple linear regression analysis, apoA-I FCR alone accounted for 66% of the variability in HDL-C; two other variables accounted for an additional 7%. Due to the importance of apoA- I FCR, its determinants were sought among the remaining variables.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				A. Basu, H. Tang, C. E. Lewis, K. North, J. D. Curb, T. Quertermous, T. H. Mosley, E. Boerwinkle, X. Zhu, and N. J. Risch Admixture mapping of quantitative trait loci for blood lipids in African-Americans Hum. Mol. Genet., June 1, 2009; 18(11): 2091 - 2098. [Abstract] [Full Text] [PDF]

				J. S. Millar, D. Duffy, R. Gadi, L. T. Bloedon, R. L. Dunbar, M. L. Wolfe, R. Movva, A. Shah, I. V. Fuki, M. McCoy, et al. Potent and Selective PPAR-{alpha} Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., January 1, 2009; 29(1): 140 - 146. [Abstract] [Full Text] [PDF]

				C. Wolfrum, J. J. Howell, E. Ndungo, and M. Stoffel Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M J. Biol. Chem., June 13, 2008; 283(24): 16940 - 16949. [Abstract] [Full Text] [PDF]

				G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects J. Lipid Res., March 1, 2008; 49(3): 635 - 643. [Abstract] [Full Text] [PDF]

				E. M. M. Ooi, G. F. Watts, P. J. Nestel, D. Sviridov, A. Hoang, and P. H. R. Barrett Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 430 - 437. [Abstract] [Full Text] [PDF]

				S. Rashid, B. W. Patterson, and G. F. Lewis Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? J. Lipid Res., August 1, 2006; 47(8): 1631 - 1642. [Abstract] [Full Text] [PDF]

				G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]

				R. Hovorka, M. N. Nanjee, C. J. Cooke, I. P. Miller, W. L. Olszewski, and N. E. Miller Mass kinetics of apolipoprotein A-I in interstitial fluid after administration of intravenous apolipoprotein A-I/lecithin discs in humans J. Lipid Res., May 1, 2006; 47(5): 975 - 981. [Abstract] [Full Text] [PDF]

				M.-C. Blatter Garin, X. Moren, and R. W. James Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I J. Lipid Res., March 1, 2006; 47(3): 515 - 520. [Abstract] [Full Text] [PDF]

				J. Ji, G. F. Watts, A. G. Johnson, D. C. Chan, E. M. M. Ooi, K.-A. Rye, A. P. Serone, and P. H. R. Barrett High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 973 - 979. [Abstract] [Full Text] [PDF]

				G. F. Lewis and D. J. Rader New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport Circ. Res., June 24, 2005; 96(12): 1221 - 1232. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, M. R. Diffenderfer, J. S. Millar, C. Nartsupha, B. F. Asztalos, F. K. Welty, M. L. Wolfe, M. Rudling, I. Bjorkhem, B. Angelin, et al. Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1057 - 1064. [Abstract] [Full Text] [PDF]

				M.-C. B. Garin, B. Kalix, A. Morabia, and R. W. James Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2264 - 2269. [Abstract] [Full Text] [PDF]

				D. Yan, M. Navab, C. Bruce, A. M. Fogelman, and X.-C. Jiang PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity J. Lipid Res., October 1, 2004; 45(10): 1852 - 1858. [Abstract] [Full Text] [PDF]

				K. Okubo, K. Ikewaki, S. Sakai, N. Tada, Y. Kawaguchi, and S. Mochizuki Abnormal HDL Apolipoprotein A-I and A-II Kinetics in Hemodialysis Patients: A Stable Isotope Study J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1008 - 1015. [Abstract] [Full Text] [PDF]

				A. M. Gotto Jr and E. A. Brinton Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update J. Am. Coll. Cardiol., March 3, 2004; 43(5): 717 - 724. [Abstract] [Full Text] [PDF]

				D. J Freeman, N. J Samani, V. Wilson, A. D McMahon, P. S Braund, S. Cheng, M. J Caslake, C. J Packard, D. Gaffney, and on behalf of the West of Scotland Study Group A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study Eur. Heart J., October 2, 2003; 24(20): 1833 - 1842. [Abstract] [Full Text] [PDF]

				J. S. Cohn, R. Batal, M. Tremblay, H. Jacques, L. Veilleux, C. Rodriguez, O. Mamer, and J. Davignon Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism J. Lipid Res., October 1, 2003; 44(10): 1976 - 1983. [Abstract] [Full Text] [PDF]

				F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF]

				G. F. Watts, P. H. R. Barrett, J. Ji, A. P. Serone, D. C. Chan, K. D. Croft, F. Loehrer, and A. G. Johnson Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome Diabetes, March 1, 2003; 52(3): 803 - 811. [Abstract] [Full Text] [PDF]

				J. Julve, J. C. Escola-Gil, V. Ribas, F. Gonzalez-Sastre, J. Ordonez-Llanos, J. L. Sanchez-Quesada, and F. Blanco-Vaca Mechanisms of HDL deficiency in mice overexpressing human apoA-II J. Lipid Res., October 1, 2002; 43(10): 1734 - 1742. [Abstract] [Full Text] [PDF]

				N. Mendez-Sanchez, V. Gonzalez, A. C. King-Martinez, H. Sanchez, and M. Uribe Plasma Leptin and the Cholesterol Saturation of Bile Are Correlated in Obese Women after Weight Loss J. Nutr., August 1, 2002; 132(8): 2195 - 2198. [Abstract] [Full Text] [PDF]

				U. J.F. Tietge, C. Maugeais, S. Lund-Katz, D. Grass, F. C. deBeer, and D. J. Rader Human Secretory Phospholipase A2 Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1213 - 1218. [Abstract] [Full Text] [PDF]

				C. M. Hoehner, K. J. Greenlund, S. Rith-Najarian, M. L. Casper, and W. M. McClellan Association of the Insulin Resistance Syndrome and Microalbuminuria among Nondiabetic Native Americans.The Inter-Tribal Heart Project J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1626 - 1634. [Abstract] [Full Text] [PDF]

				S. Rashid, P. H. R. Barrett, K. D. Uffelman, T. Watanabe, K. Adeli, and G. F. Lewis Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 483 - 487. [Abstract] [Full Text] [PDF]

				J. M. Martin-Campos, J. Julve, J. C. Escola, J. Ordonez-Llanos, J. Gomez, J. Binimelis, F. Gonzalez-Sastre, and F. Blanco-Vaca ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia J. Lipid Res., January 1, 2002; 43(1): 115 - 123. [Abstract] [Full Text] [PDF]

				A. Pascot, I. Lemieux, D. Prud'homme, A. Tremblay, A. Nadeau, C. Couillard, J. Bergeron, B. Lamarche, and J.-P. Despres Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity J. Lipid Res., December 1, 2001; 42(12): 2007 - 2014. [Abstract] [Full Text] [PDF]

				A. D. Attie, J. P. Kastelein, and M. R. Hayden Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis J. Lipid Res., November 1, 2001; 42(11): 1717 - 1726. [Abstract] [Full Text] [PDF]

				R. Frénais, H. Nazih, K. Ouguerram, C. Maugeais, Y. Zaïr, J. M. Bard, B. Charbonnel, T. Magot, and M. Krempf In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1962 - 1967. [Abstract] [Full Text]

				S. Rashid, K. D. Uffelman, P. H. R. Barrett, P. Vicini, K. Adeli, and G. F. Lewis Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits J. Lipid Res., February 1, 2001; 42(2): 265 - 271. [Abstract] [Full Text]

				M. Mehrabian, L. W. Castellani, P.-Z. Wen, J. Wong, T. Rithaporn, S. Y. Hama, G. P. Hough, D. Johnson, J. J. Albers, G. A. Mottino, et al. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei C57BL/6J) J. Lipid Res., December 1, 2000; 41(12): 1936 - 1946. [Abstract] [Full Text]

				E. R. De Oliveira e Silva, D. Foster, M. McGee Harper, C. E. Seidman, J. D. Smith, J. L. Breslow, and E. A. Brinton Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II Circulation, November 7, 2000; 102(19): 2347 - 2352. [Abstract] [Full Text] [PDF]

				A. Tailleux, M. Bouly, G. Luc, G. Castro, J.-M. Caillaud, N. Hennuyer, P. Poulain, J.-C. Fruchart, N. Duverger, and C. Fievet Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2453 - 2458. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size J. Lipid Res., July 1, 2000; 41(7): 1125 - 1135. [Abstract] [Full Text]

				A. P. Goldberg, M. J. Busby-Whitehead, L. I. Katzel, R. M. Krauss, M. Lumpkin, and J. M. Hagberg Cardiovascular Fitness, Body Composition, and Lipoprotein Lipid Metabolism in Older Men J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2000; 55(6): 342M - 349. [Abstract] [Full Text]

				N. Elias, B. W. Patterson, and G. Schonfeld In Vivo Metabolism of ApoB, ApoA-I, and VLDL Triglycerides in a Form of Hypobetalipoproteinemia Not Linked to the ApoB Gene Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1309 - 1315. [Abstract] [Full Text] [PDF]

				B. Asztalos, M. Lefevre, L. Wong, T. A. Foster, R. Tulley, M. Windhauser, W. Zhang, and P. S. Roheim Differential response to low-fat diet between low and normal HDL-cholesterol subjects J. Lipid Res., March 1, 2000; 41(3): 321 - 328. [Abstract] [Full Text]

				W. Velez-Carrasco, A. H. Lichtenstein, Z. Li, G. G. Dolnikowski, S. Lamon-Fava, F. K. Welty, and E. J. Schaefer Apolipoprotein A-I and A-II Kinetic Parameters as Assessed by Endogenous Labeling With [2H3]Leucine in Middle-Aged and Elderly Men and Women Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 801 - 806. [Abstract] [Full Text] [PDF]

				S. Qin, K. Kawano, C. Bruce, M. Lin, C. Bisgaier, A. R. Tall, and X.-c. Jiang Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins J. Lipid Res., February 1, 2000; 41(2): 269 - 276. [Abstract] [Full Text]

				B. Bülow, L. Hagmar, J. Eskilsson, and E. M. Erfurth Hypopituitary Females Have a High Incidence of Cardiovascular Morbidity and an Increased Prevalence of Cardiovascular Risk Factors J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 574 - 584. [Abstract] [Full Text]

				M. N. Nanjee and E. A. Brinton Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography Clin. Chem., February 1, 2000; 46(2): 207 - 223. [Abstract] [Full Text] [PDF]

				E. R. De Oliveirae Silva, M. Kong, Z. Han, C. Starr, E. M. Kass, S.-H. H. Juo, D. Foster, H. M. Dansky, M. Merkel, K. Cundey, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females J. Lipid Res., July 1, 1999; 40(7): 1211 - 1221. [Abstract] [Full Text]

				W. Weng, N. A. Brandenburg, S. Zhong, J. Halkias, L. Wu, X.-c. Jiang, A. Tall, and J. L. Breslow ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice J. Lipid Res., June 1, 1999; 40(6): 1064 - 1070. [Abstract] [Full Text]

				M. Jauhiainen, J. Huuskonen, M. Baumann, J. Metso, T. Oka, T. Egashira, H. Hattori, V. M. Olkkonen, and C. Ehnholm Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I J. Lipid Res., April 1, 1999; 40(4): 654 - 664. [Abstract] [Full Text]

				S. Braschi, T. A-M. Neville, M.-C. Vohl, and D. L. Sparks Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo J. Lipid Res., March 1, 1999; 40(3): 522 - 532. [Abstract] [Full Text]

				D. L. Silver, X.-c. Jiang, and A. R. Tall Increased High Density Lipoprotein (HDL), Defective Hepatic Catabolism of ApoA-I and ApoA-II, and Decreased ApoA-I mRNA in ob/ob Mice. POSSIBLE ROLE OF LEPTIN IN STIMULATION OF HDL TURNOVER J. Biol. Chem., February 12, 1999; 274(7): 4140 - 4146. [Abstract] [Full Text] [PDF]

				N. Mekki, M. A. Christofilis, M. Charbonnier, C. Atlan-Gepner, C. Defoort, C. Juhel, P. Borel, H. Portugal, A. M. Pauli, B. Vialettes, et al. Influence of Obesity and Body Fat Distribution on Postprandial Lipemia and Triglyceride-Rich Lipoproteins in Adult Women J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 184 - 191. [Abstract] [Full Text]

				P. Colvin, E. Moriguchi, H. Barrett, J. Parks, and L. Rudel Production rate determines plasma concentration of large high density lipoprotein in non-human primates J. Lipid Res., October 1, 1998; 39(10): 2076 - 2085. [Abstract] [Full Text]

				M. E. Brousseau, J. Wang, S. J. Demosky , Jr., B. L. Vaisman, G. D. Talley, S. Santamarina-Fojo, H. B. Brewer , Jr., and J. M. Hoeg Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase J. Lipid Res., August 1, 1998; 39(8): 1558 - 1567. [Abstract] [Full Text]

				K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung. Effect of Thyroid Dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2921 - 2924. [Abstract] [Full Text]

				T. V. Fungwe, B. J. Kudchodkar, A. G. Lacko, and L. Dory Fatty Acids Modulate Lecithin:Cholesterol Acyltransferase Secretion Independently of Effects on Triglyceride Secretion in Primary Rat Hepatocytes J. Nutr., August 1, 1998; 128(8): 1270 - 1275. [Abstract] [Full Text]

				B. Lamarche, K. D. Uffelman, G. Steiner, P. H. R. Barrett, and G. F. Lewis Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model J. Lipid Res., June 1, 1998; 39(6): 1162 - 1172. [Abstract] [Full Text]

				R. Batal, M. Tremblay, L. Krimbou, O. Mamer, J. Davignon, J. Genest Jr, and J. S. Cohn Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 655 - 664. [Abstract] [Full Text] [PDF]

				W. Huang, J. Sasaki, A. Matsunaga, H. Nanimatsu, K. Moriyama, H. Han, M. Kugi, T. Koga, K. Yamaguchi, and K. Arakawa A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 389 - 396. [Abstract] [Full Text] [PDF]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. Joven, E. Vilella, M. C. Cheung, W. V. Carrasco, J. M. Ordovas, G. Dolnikowski, and E. J. Schaefer Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3513 - 3518. [Abstract] [Full Text]

				B. F. Asztalos, M. Lefevre, T. A. Foster, R. Tulley, M. Windhauser, L. Wong, and P. S. Roheim Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1885 - 1893. [Abstract] [Full Text]

				K. A. S. Al-Shoumer, K. H. Cox, C. L. Hughes, W. Richmond, and D. G. Johnston Fasting and Postprandial Lipid Abnormalities in Hypopituitary Women Receiving Conventional Replacement Therapy J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2653 - 2659. [Abstract] [Full Text] [PDF]

				S. Levak-Frank, P. H. Weinstock, T. Hayek, R. Verdery, W. Hofmann, R. Ramakrishnan, W. Sattler, J. L. Breslow, and R. Zechner Induced Mutant Mice Expressing Lipoprotein Lipase Exclusively in Muscle Have Subnormal Triglycerides yet Reduced High Density Lipoprotein Cholesterol Levels in Plasma J. Biol. Chem., July 4, 1997; 272(27): 17182 - 17190. [Abstract] [Full Text] [PDF]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients: Role of Cholesterol-Ester Transfer Protein and Lecithin Cholesteryl Acyl Transferase Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 56 - 63. [Abstract] [Full Text]

				D. L. Sprecher, B. V. Harris, E. A. Stein, P. S. Bellet, L. M. Keilson, and L. A. Simbartl Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes: A Preliminary Report Circulation, December 15, 1996; 94(12): 3239 - 3245. [Abstract] [Full Text]

				W. Weng and J. L. Breslow Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility PNAS, December 10, 1996; 93(25): 14788 - 14794. [Abstract] [Full Text] [PDF]

				N. Duverger, C. Viglietta, L. Berthou, F. Emmanuel, A. Tailleux, L. Parmentier-Nihoul, B. Laine, C. Fievet, G. Castro, J. C. Fruchart, et al. Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1424 - 1429. [Abstract] [Full Text]

				S. Seguret-Mace, M. Latta-Mahieu, G. Castro, G. Luc, J.-C. Fruchart, E. Rubin, P. Denefle, and N. Duverger Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene Circulation, November 1, 1996; 94(9): 2177 - 2184. [Abstract] [Full Text]

				E. A. Brinton Oral Estrogen Replacement Therapy in Postmenopausal Women Selectively Raises Levels and Production Rates of Lipoprotein A-I and Lowers Hepatic Lipase Activity Without Lowering the Fractional Catabolic Rate Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 431 - 440. [Abstract] [Full Text]

				J. M. Hoeg, B. L. Vaisman, S. J. Demosky Jr., S. M. Meyn, G. D. Talley, R. F. Hoyt Jr., S. Feldman, A. M. Bérard, N. Sakai, D. Wood, et al. Lecithin:Cholesterol Acyltransferase Overexpression Generates Hyperalpha-lipoproteinemia and a Nonatherogenic Lipoprotein Pattern in Transgenic Rabbits J. Biol. Chem., February 23, 1996; 271(8): 4396 - 4402. [Abstract] [Full Text] [PDF]

				C. M. Beard, R. J. Barnard, D. C. Robbins, J. M. Ordovas, and E. J. Schaefer Effects of Diet and Exercise on Qualitative and Quantitative Measures of LDL and Its Susceptibility to Oxidation Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 201 - 207. [Abstract] [Full Text]

				M. C. Mahaney, J. Blangero, A. G. Comuzzie, J. L. VandeBerg, M. P. Stern, and J. W. MacCluer Plasma HDL Cholesterol, Triglycerides, and Adiposity : A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study Circulation, December 1, 1995; 92(11): 3240 - 3248. [Abstract] [Full Text]

				N. Azrolan, H. Odaka, J. L. Breslow, and E. A. Fisher Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool J. Biol. Chem., August 25, 1995; 270(34): 19833 - 19838. [Abstract] [Full Text] [PDF]

				F. Tato, G. L. Vega, and S. M. Grundy Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 446 - 451. [Abstract] [Full Text]

				K. N. Liadaki, T. Liu, S. Xu, B. Y. Ishida, P. N. Duchateaux, J. P. Krieger, J. Kane, M. Krieger, and V. I. Zannis Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I. EFFECT OF LIPID ASSOCIATION AND APOA-I MUTATIONS ON RECEPTOR BINDING J. Biol. Chem., July 7, 2000; 275(28): 21262 - 21271. [Abstract] [Full Text] [PDF]